Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767

Karilyn Gower, Press Officer
w. (202) 588-7779

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog

Follow us on Twitter

October 11, 2012

donesian Government Takes Bold Stance to Reduce Costs of AIDS Medications, Potentially Saving Thousands of Lives

WASHINGTON, D.C.- With a single decree, Indonesian President Dr. H. Susilo Bambang Yudhoyono has taken a quiet but exceptionally important step to expand access to medicines, potentially saving and improving the lives of tens of thousands of people living with HIV/AIDS and hepatitis B.

Indonesia’s action sets a powerful example for other countries and a critical precedent for global public health. The decree licenses patents for a slate of HIV medicines and represents one of the most robust uses of pharmaceutical patent licensing power ever used by a country.

By taking such a bold stance, President Yudhoyono and all of Indonesia can take great pride in standing up for the right of those suffering from HIV/AIDS and hepatitits B to get the treatment they need. This action is part of an effort to greatly expand access to newer and more useful AIDS therapy in Indonesia.

Public Citizen has provided technical assistance to patient advocates in Indonesia on this issue. We congratulate the work of Sindi Putri and Abdullah Denovan, as well as their colleagues at International Treatment Preparedness Coalition Indonesia and JOTHI, among other organizations, who are helping advance access to these important medications in Indonesia.

For more information, including a copy of the decree (in Indonesian and a rough unofficial English translation), analysis, a table of the licensed medicines and more on Indonesia’s response to HIV and hepatitis B, visit www.citizen.org/actions-indonesia.

To read more about the global campaign to improve access to second-line HIV/AIDS treatment, visit www.citizen.org/Kaletra-campaign.

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.